|The following article features coverage from the European Society for Medical Oncology (ESMO) 2019 meeting. Click here to read more of Cancer Therapy Advisor‘s conference coverage.|
The European Society of Medical Oncology (ESMO) 2019 Congress will take place from Friday, September 27, through Tuesday, October 1, 2019, in Barcelona, Spain.
The ESMO 2019 Congress is a meeting where oncology professionals from around the world gather to attend scientific and educational sessions aimed at highlighting key advances in medical research that have the potential to change practice. In addition to poster presentations, expert presenters will be sharing and debating the latest in translational cancer science and partaking in multidisciplinary conversations aimed at improving the practice of cancer care.
Cancer Therapy Advisor’s coverage will highlight the most important and practically relevant research being presented throughout the weekend at ESMO 2019 Congress. News articles will span across a variety of disease states including lung cancer, renal cell carcinoma, neuroblastoma, breast cancer, colorectal cancer, and skin cancer, and will also summarize scientific research that pertains to general oncology practice.
As news breaks throughout the weekend, readers can anticipate news summaries that concisely highlight the most recent findings and updated data interpretations from trials including CheckMate 227, the SORCE trial, BEACON-Neuroblastoma, MONARCH 2, YoungPearl, and the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial, and much more.
Scientific presentations at ESMO 2019 Congress are aimed at identifying and explaining the latest trends in global research, methods, and technology in the treatment of cancers. Expert presenters will examine the significance of novel approaches to the medical and surgical management of cancers and share their research findings with a global audience of oncology health care professionals.
Visit Cancer Therapy Advisor’s conference section to stay up to date on the continuous coverage from ESMO 2019 Congress.